Fasting Study of Metformin Hydrochloride ER Tablets 750 mg and Glucophage® XR Tablets 750 mg

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The objective of this study was to investigate the bioequivalence of Mylan\'s metformin hydrochloride ER tablets to Bristol-Myers Squibb\'s Glucophage® XR tablets following a single, oral 750 mg (1 x 750 mg) dose administered under fasting conditions.
Epistemonikos ID: ef9f140eaf91fa6d516a95130ca57d23a611c1e3
First added on: May 04, 2024